Dietary Intervention of Stress-Induced Neurovegetative Disorders With a Specific Amino Acid Composition (asn01)
Study Details
Study Description
Brief Summary
Psychosocial stress leads to altered neuroendocrine functions, such as serotonergic dysfunction, as well as alterations of the autonomic nervous system and the hypothalamic-pituitary-adrenal (HPA) axis activity resulting in an imbalance between inhibitory and excitatory neurotransmitters. Clinical consequences include, inter alia, neurovegetative disorders, higher resting heart rate, hypertension, depressive symptoms, sleep disturbances, irregular body-weight changes, and insulin resistance. Poor dietary intake of the essential amino acid L-tryptophane as a precursor to 5-hydroxytryptamine (HT, serotonin) increases sensitivity to stress.
It is therefore the investigators hypothesis that daily oral administration of an amino acid mixture (dosage 3.8 g/day) with micronutrients specifically designed to decrease neurovegetative disorders will target these neuroendocrine and metabolic alterations in adults with psychosocial stress. The principal endpoints will be a decrease in points in the psychological-neurological questionnaire (PNF).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: amino acid composition (asn01) Dietary supplement: specific amino acid composition with micronutrients |
Dietary Supplement: amino acid composition (asn01)
Amino acid composition with micronutrients, once a day (in the evening, 2 hours after dinner) content of a sachet mixed with 200 ml water.
Duration: 12 weeks
Other Names:
|
Placebo Comparator: Sugar powder Placebo contains no amino acids and no micronutrients and is identical in appearance and solution properties. |
Other: Placebo
Placebo; once a day (in the evening, 2 hours after dinner) content of a sachet mixed with 200 ml water.
Placebo contains no amino acids and micronutrients and is identical in appearance and solution properties.
Duration: 12 weeks
|
Outcome Measures
Primary Outcome Measures
- Psychological neurological questionnaire (PNF) [12-week dietary intervention]
Pre-post intervention changes in total number of points PNF
Secondary Outcome Measures
- Psychological neurological questionnaire (PNF) [12-week dietary intervention]
Pre-post improvement in total number of points from the psychological-neurological questionnaire (PNF) about 10 Points or more
- Salivary cortisol concentration (30 minutes after waking in the morning) [12-week dietary intervention]
Absolute difference between cortisol concentration at baseline and 12 weeks
- Salivary cortisol concentration (in the evening between 8 and 10 pm, 2 hours after dinner) [12-week dietary intervention]
Absolute difference between cortisol concentration at baseline and 12 weeks
- Serotonin concentration in blood [12-week dietary intervention]
Absolute difference between serotonin concentration at baseline and 12 weeks
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age: 18-65 Years
-
Psychological-Neurological Questionnaire (PNF): 30 - 50 Points
Exclusion Criteria:
-
Age: < 18 and > 65 Years
-
Psychological neurological questionnaire (PNF): < 30 and > 50 Points
-
Resting heart rate: < 70/min
-
Supplementation with dietary supplements or drugs which contains amino acids, vitamins and other micronutrients
-
Therapy with antipsychotic drugs such as tranquilizer, antidepressants
-
acute and chronic diarrhea
-
Psychological-neurological or psychiatric therapy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Cardiological Outpatient Practice Elke Parsi, MD | Berlin | Germany | 13053 |
Sponsors and Collaborators
- Kyberg Vital GmbH
Investigators
- Principal Investigator: Christine Metzner, Professor MD, Bonn Education Association for Dietetics r.A., Cologne, Germany
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Kyberg-02